JP2015513903A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015513903A5 JP2015513903A5 JP2015503318A JP2015503318A JP2015513903A5 JP 2015513903 A5 JP2015513903 A5 JP 2015513903A5 JP 2015503318 A JP2015503318 A JP 2015503318A JP 2015503318 A JP2015503318 A JP 2015503318A JP 2015513903 A5 JP2015513903 A5 JP 2015513903A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- amino acid
- kallidin
- antibody
- arg
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018218861A JP6912441B2 (ja) | 2012-03-28 | 2018-11-22 | ブラジキニンｂ１受容体リガンドに対する抗体 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261616845P | 2012-03-28 | 2012-03-28 | |
| US61/616,845 | 2012-03-28 | ||
| FR1350953 | 2013-02-04 | ||
| FR1350953 | 2013-02-04 | ||
| PCT/US2013/031836 WO2013148296A1 (en) | 2012-03-28 | 2013-03-15 | Antibodies to bradykinin b1 receptor ligands |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018218861A Division JP6912441B2 (ja) | 2012-03-28 | 2018-11-22 | ブラジキニンｂ１受容体リガンドに対する抗体 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015513903A JP2015513903A (ja) | 2015-05-18 |
| JP2015513903A5 true JP2015513903A5 (https=) | 2016-04-07 |
| JP6779012B2 JP6779012B2 (ja) | 2020-11-04 |
Family
ID=49261064
Family Applications (5)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015503318A Active JP6779012B2 (ja) | 2012-03-28 | 2013-03-15 | ブラジキニンｂ１受容体リガンドに対する抗体 |
| JP2018218861A Active JP6912441B2 (ja) | 2012-03-28 | 2018-11-22 | ブラジキニンｂ１受容体リガンドに対する抗体 |
| JP2021112483A Active JP7411609B2 (ja) | 2012-03-28 | 2021-07-07 | ブラジキニンｂ１受容体リガンドに対する抗体 |
| JP2023216462A Pending JP2024038036A (ja) | 2012-03-28 | 2023-12-22 | ブラジキニンｂ１受容体リガンドに対する抗体 |
| JP2025104387A Pending JP2025134874A (ja) | 2012-03-28 | 2025-06-20 | ブラジキニンｂ１受容体リガンドに対する抗体 |
Family Applications After (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018218861A Active JP6912441B2 (ja) | 2012-03-28 | 2018-11-22 | ブラジキニンｂ１受容体リガンドに対する抗体 |
| JP2021112483A Active JP7411609B2 (ja) | 2012-03-28 | 2021-07-07 | ブラジキニンｂ１受容体リガンドに対する抗体 |
| JP2023216462A Pending JP2024038036A (ja) | 2012-03-28 | 2023-12-22 | ブラジキニンｂ１受容体リガンドに対する抗体 |
| JP2025104387A Pending JP2025134874A (ja) | 2012-03-28 | 2025-06-20 | ブラジキニンｂ１受容体リガンドに対する抗体 |
Country Status (38)
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS57413B1 (sr) * | 2012-03-28 | 2018-09-28 | Sanofi Sa | Antitela za ligande bradikinin b1 receptora |
| CA2902026C (en) | 2013-03-13 | 2023-08-29 | Prothena Biosciences Limited | Tau immunotherapy |
| CN105504049B (zh) * | 2014-09-26 | 2019-07-05 | 艾托金生物医药（苏州）有限公司 | 宫颈癌相关的hpv e7蛋白单克隆抗体及其应用 |
| EP3390439B1 (en) | 2015-12-15 | 2025-03-12 | Takeda Pharmaceutical Company Limited | Peptide quantitation assay for differentiating full-length high molecular weight kininogen (hmwk) and cleaved hmwk |
| EP3448874A4 (en) | 2016-04-29 | 2020-04-22 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| EP3448987A4 (en) | 2016-04-29 | 2020-05-27 | Voyager Therapeutics, Inc. | COMPOSITIONS FOR TREATING A DISEASE |
| EP3452507B1 (en) | 2016-05-02 | 2022-10-19 | Prothena Biosciences Limited | Tau immunotherapy |
| PE20190208A1 (es) | 2016-05-02 | 2019-02-07 | Prothena Biosciences Ltd | Anticuerpos que reconocen tau |
| CA3022515A1 (en) | 2016-05-02 | 2017-11-09 | Prothena Biosciences Limited | Antibodies recognizing tau |
| JOP20190100A1 (ar) | 2016-11-19 | 2019-05-01 | Potenza Therapeutics Inc | بروتينات ربط مولد ضد مضاد لـ gitr وطرق استخدامها |
| CN110881274B (zh) | 2017-05-02 | 2024-11-15 | 普罗塞纳生物科学有限公司 | 识别tau的抗体 |
| BR112019023111A2 (pt) * | 2017-05-08 | 2020-07-28 | Adimab, Llc | domínios de ligação anti-cd3 e anticorpos compreendendo os mesmos, e métodos para sua geração e uso |
| WO2019148186A1 (en) * | 2018-01-29 | 2019-08-01 | Silarus Therapeutics, Inc. | Antibodies binding erfe and methods of use |
| EP3935083A4 (en) | 2019-03-03 | 2022-11-30 | Prothena Biosciences Limited | Antibodies recognizing tau |
| KR20220035369A (ko) | 2019-06-07 | 2022-03-22 | 아디맵 엘엘씨 | 고 친화도 항-cd3 항체, 및 이의 생성 및 사용 방법 |
| CN119306824B (zh) * | 2024-10-08 | 2025-09-26 | 江苏埃尔迪生物科技有限公司 | 一种全价展示scFv的通用型M13噬菌体探针及其构建方法和应用 |
Family Cites Families (69)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4741900A (en) | 1982-11-16 | 1988-05-03 | Cytogen Corporation | Antibody-metal ion complexes |
| GB8308235D0 (en) | 1983-03-25 | 1983-05-05 | Celltech Ltd | Polypeptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5807715A (en) | 1984-08-27 | 1998-09-15 | The Board Of Trustees Of The Leland Stanford Junior University | Methods and transformed mammalian lymphocyte cells for producing functional antigen-binding protein including chimeric immunoglobulin |
| GB8607679D0 (en) | 1986-03-27 | 1986-04-30 | Winter G P | Recombinant dna product |
| US5225539A (en) | 1986-03-27 | 1993-07-06 | Medical Research Council | Recombinant altered antibodies and methods of making altered antibodies |
| WO1988007089A1 (en) | 1987-03-18 | 1988-09-22 | Medical Research Council | Altered antibodies |
| ATE120454T1 (de) | 1988-06-14 | 1995-04-15 | Cetus Oncology Corp | Kupplungsmittel und sterisch gehinderte, mit disulfid gebundene konjugate daraus. |
| US6780613B1 (en) | 1988-10-28 | 2004-08-24 | Genentech, Inc. | Growth hormone variants |
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| IE63847B1 (en) | 1989-05-05 | 1995-06-14 | Res Dev Foundation | A novel antibody delivery system for biological response modifiers |
| US5460785A (en) | 1989-08-09 | 1995-10-24 | Rhomed Incorporated | Direct labeling of antibodies and other protein with metal ions |
| GB8928874D0 (en) | 1989-12-21 | 1990-02-28 | Celltech Ltd | Humanised antibodies |
| US5314995A (en) | 1990-01-22 | 1994-05-24 | Oncogen | Therapeutic interleukin-2-antibody based fusion proteins |
| AU654811B2 (en) | 1990-03-20 | 1994-11-24 | Trustees Of Columbia University In The City Of New York, The | Chimeric antibodies with receptor binding ligands in place of their constant region |
| DE69133036T2 (de) | 1990-11-09 | 2003-02-06 | Stephen D. Gillies | Cytokine immunokonjugate |
| EP0519596B1 (en) | 1991-05-17 | 2005-02-23 | Merck & Co. Inc. | A method for reducing the immunogenicity of antibody variable domains |
| ES2136092T3 (es) | 1991-09-23 | 1999-11-16 | Medical Res Council | Procedimientos para la produccion de anticuerpos humanizados. |
| US5639641A (en) | 1992-09-09 | 1997-06-17 | Immunogen Inc. | Resurfacing of rodent antibodies |
| GB9422383D0 (en) | 1994-11-05 | 1995-01-04 | Wellcome Found | Antibodies |
| US5869046A (en) | 1995-04-14 | 1999-02-09 | Genentech, Inc. | Altered polypeptides with increased half-life |
| US5739277A (en) | 1995-04-14 | 1998-04-14 | Genentech Inc. | Altered polypeptides with increased half-life |
| US6096871A (en) | 1995-04-14 | 2000-08-01 | Genentech, Inc. | Polypeptides altered to contain an epitope from the Fc region of an IgG molecule for increased half-life |
| US6121022A (en) | 1995-04-14 | 2000-09-19 | Genentech, Inc. | Altered polypeptides with increased half-life |
| GB9524973D0 (en) | 1995-12-06 | 1996-02-07 | Lynxvale Ltd | Viral vectors |
| ATE386809T1 (de) | 1996-08-02 | 2008-03-15 | Bristol Myers Squibb Co | Ein verfahren zur inhibierung immunglobulininduzierter toxizität aufgrund von der verwendung von immunoglobinen in therapie und in vivo diagnostik |
| WO1998023289A1 (en) | 1996-11-27 | 1998-06-04 | The General Hospital Corporation | MODULATION OF IgG BINDING TO FcRn |
| US6277375B1 (en) | 1997-03-03 | 2001-08-21 | Board Of Regents, The University Of Texas System | Immunoglobulin-like domains with increased half-lives |
| WO1998052976A1 (en) | 1997-05-21 | 1998-11-26 | Biovation Limited | Method for the production of non-immunogenic proteins |
| US6242195B1 (en) | 1998-04-02 | 2001-06-05 | Genentech, Inc. | Methods for determining binding of an analyte to a receptor |
| US6528624B1 (en) | 1998-04-02 | 2003-03-04 | Genentech, Inc. | Polypeptide variants |
| US6194551B1 (en) | 1998-04-02 | 2001-02-27 | Genentech, Inc. | Polypeptide variants |
| ES2292236T3 (es) | 1998-04-02 | 2008-03-01 | Genentech, Inc. | Variantes de anticuerpos y sus fragmentos. |
| GB9809951D0 (en) | 1998-05-08 | 1998-07-08 | Univ Cambridge Tech | Binding molecules |
| EP1105427A2 (en) | 1998-08-17 | 2001-06-13 | Abgenix, Inc. | Generation of modified molecules with increased serum half-lives |
| EP1006183A1 (en) | 1998-12-03 | 2000-06-07 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Recombinant soluble Fc receptors |
| WO2000034317A2 (en) | 1998-12-08 | 2000-06-15 | Biovation Limited | Method for reducing immunogenicity of proteins |
| US6737056B1 (en) | 1999-01-15 | 2004-05-18 | Genentech, Inc. | Polypeptide variants with altered effector function |
| HU230769B1 (hu) | 1999-01-15 | 2018-03-28 | Genentech Inc. | Módosított effektor-funkciójú polipeptid-változatok |
| US20020102208A1 (en) | 1999-03-01 | 2002-08-01 | Paul Chinn | Radiolabeling kit and binding assay |
| GB0029407D0 (en) | 2000-12-01 | 2001-01-17 | Affitech As | Product |
| PT1355919E (pt) | 2000-12-12 | 2011-03-02 | Medimmune Llc | Moléculas com semivida longa, composições que as contêm e suas utilizações |
| US20040002587A1 (en) | 2002-02-20 | 2004-01-01 | Watkins Jeffry D. | Fc region variants |
| US20040132101A1 (en) | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
| CA2478011C (en) | 2002-03-01 | 2013-05-21 | Immunomedics, Inc. | Bispecific antibody point mutations for enhancing rate of clearance |
| EP1534335B9 (en) | 2002-08-14 | 2016-01-13 | Macrogenics, Inc. | Fcgammariib-specific antibodies and methods of use thereof |
| WO2004029207A2 (en) | 2002-09-27 | 2004-04-08 | Xencor Inc. | Optimized fc variants and methods for their generation |
| DE60334141D1 (de) | 2002-10-15 | 2010-10-21 | Facet Biotech Corp | VERÄNDERUNG VON FcRn-BINDUNGSAFFINITÄTEN ODER VON SERUMHALBWERTSZEITEN VON ANTIKÖRPERN MITTELS MUTAGENESE |
| JP2006524039A (ja) | 2003-01-09 | 2006-10-26 | マクロジェニクス，インコーポレーテッド | 変異型Ｆｃ領域を含む抗体の同定および作製ならびにその利用法 |
| CN1871259A (zh) | 2003-08-22 | 2006-11-29 | 比奥根艾迪克Ma公司 | 具有改变的效应物功能的经改进的抗体和制备它的方法 |
| GB0324368D0 (en) | 2003-10-17 | 2003-11-19 | Univ Cambridge Tech | Polypeptides including modified constant regions |
| WO2005047327A2 (en) | 2003-11-12 | 2005-05-26 | Biogen Idec Ma Inc. | NEONATAL Fc RECEPTOR (FcRn)-BINDING POLYPEPTIDE VARIANTS, DIMERIC Fc BINDING PROTEINS AND METHODS RELATED THERETO |
| US20050249723A1 (en) | 2003-12-22 | 2005-11-10 | Xencor, Inc. | Fc polypeptides with novel Fc ligand binding sites |
| CA2552788C (en) | 2004-01-12 | 2013-09-24 | Applied Molecular Evolution, Inc. | Fc region variants |
| EP1737890A2 (en) | 2004-03-24 | 2007-01-03 | Xencor, Inc. | Immunoglobulin variants outside the fc region |
| WO2005123780A2 (en) | 2004-04-09 | 2005-12-29 | Protein Design Labs, Inc. | Alteration of fcrn binding affinities or serum half-lives of antibodies by mutagenesis |
| WO2006085967A2 (en) | 2004-07-09 | 2006-08-17 | Xencor, Inc. | OPTIMIZED ANTI-CD20 MONOCONAL ANTIBODIES HAVING Fc VARIANTS |
| CN103172731A (zh) | 2004-07-15 | 2013-06-26 | 赞科股份有限公司 | 优化的Fc变体 |
| WO2006047350A2 (en) | 2004-10-21 | 2006-05-04 | Xencor, Inc. | IgG IMMUNOGLOBULIN VARIANTS WITH OPTIMIZED EFFECTOR FUNCTION |
| KR20080015854A (ko) * | 2005-06-14 | 2008-02-20 | 사이토스 바이오테크놀로지 아게 | 항원 컨쥬게이트 및 그의 용도 |
| US7833260B2 (en) | 2006-07-20 | 2010-11-16 | Orbusneich Medical, Inc. | Bioabsorbable polymeric medical device |
| KR20090088891A (ko) * | 2006-11-15 | 2009-08-20 | 메다렉스, 인코포레이티드 | 비티엘에이에 대한 인간 단일클론 항체 및 이용 방법 |
| EP2157937B1 (en) | 2007-06-04 | 2017-03-22 | Sequent Medical, Inc. | Devices for treatment of vascular defects |
| PL2170389T3 (pl) * | 2007-06-12 | 2015-03-31 | Ac Immune Sa | Humanizowane przeciwciało przeciw amyloidowi beta |
| CN111909273B (zh) | 2007-08-29 | 2024-03-26 | 塞诺菲-安万特股份有限公司 | 人源化的抗-cxcr5抗体、其衍生物及它们的应用 |
| NZ599777A (en) * | 2007-11-07 | 2013-09-27 | Celldex Therapeutics Inc | Antibodies that bind human dendritic and epithelial cell 205 (DEC-205) |
| EP2420245A1 (en) * | 2010-08-18 | 2012-02-22 | Max-Delbrück-Centrum Für Molekulare Medizin | Therapeutic use of agonists or antagonists of bradykinin receptor 1 or 2, for modulation collateral blood vessel growth |
| RS57413B1 (sr) * | 2012-03-28 | 2018-09-28 | Sanofi Sa | Antitela za ligande bradikinin b1 receptora |
| US9958572B2 (en) | 2015-03-31 | 2018-05-01 | Halliburton Energy Services, Inc. | Synthetic test beds for fracturing optimization and methods of manufacture and use thereof |
-
2013
- 2013-03-15 RS RS20180704A patent/RS57413B1/sr unknown
- 2013-03-15 KR KR1020197030406A patent/KR102166083B1/ko active Active
- 2013-03-15 KR KR1020147029192A patent/KR102035882B1/ko active Active
- 2013-03-15 HR HRP20180928TT patent/HRP20180928T1/hr unknown
- 2013-03-15 SI SI201331066T patent/SI2831113T1/en unknown
- 2013-03-15 CN CN202510415465.1A patent/CN120441698A/zh active Pending
- 2013-03-15 HU HUE13715049A patent/HUE037720T2/hu unknown
- 2013-03-15 DK DK17179380.5T patent/DK3246339T3/da active
- 2013-03-15 CN CN202111098640.7A patent/CN113773385B/zh active Active
- 2013-03-15 EA EA201491784A patent/EA201491784A1/ru unknown
- 2013-03-15 AU AU2013240242A patent/AU2013240242B2/en not_active Ceased
- 2013-03-15 PE PE2014001473A patent/PE20142170A1/es active IP Right Grant
- 2013-03-15 ES ES13715049.6T patent/ES2673869T3/es active Active
- 2013-03-15 DK DK13715049.6T patent/DK2831113T3/en active
- 2013-03-15 SG SG11201405162YA patent/SG11201405162YA/en unknown
- 2013-03-15 PT PT137150496T patent/PT2831113T/pt unknown
- 2013-03-15 UY UY34682A patent/UY34682A/es not_active Application Discontinuation
- 2013-03-15 CA CA2868353A patent/CA2868353C/en active Active
- 2013-03-15 UA UAA201411667A patent/UA117097C2/uk unknown
- 2013-03-15 US US14/382,798 patent/US9376494B2/en active Active
- 2013-03-15 MA MA37407A patent/MA37407B1/fr unknown
- 2013-03-15 PL PL13715049T patent/PL2831113T3/pl unknown
- 2013-03-15 WO PCT/US2013/031836 patent/WO2013148296A1/en not_active Ceased
- 2013-03-15 MY MYPI2014002482A patent/MY166157A/en unknown
- 2013-03-15 CN CN201380027405.8A patent/CN104334578B/zh active Active
- 2013-03-15 KR KR1020227005891A patent/KR20220031728A/ko not_active Ceased
- 2013-03-15 SG SG10201702396QA patent/SG10201702396QA/en unknown
- 2013-03-15 EP EP13715049.6A patent/EP2831113B1/en active Active
- 2013-03-15 JP JP2015503318A patent/JP6779012B2/ja active Active
- 2013-03-15 TR TR2018/08486T patent/TR201808486T4/tr unknown
- 2013-03-15 TW TW102109162A patent/TWI605060B/zh active
- 2013-03-15 AR ARP130100847 patent/AR090352A1/es unknown
- 2013-03-15 BR BR112014024282A patent/BR112014024282A2/pt not_active IP Right Cessation
- 2013-03-15 MX MX2014011688A patent/MX361874B/es active IP Right Grant
- 2013-03-15 NZ NZ631543A patent/NZ631543A/en not_active IP Right Cessation
- 2013-03-15 EP EP17179380.5A patent/EP3246339B1/en active Active
- 2013-03-15 KR KR1020207028912A patent/KR102367723B1/ko active Active
- 2013-03-15 LT LTEP13715049.6T patent/LT2831113T/lt unknown
- 2013-03-15 MY MYPI2018701130A patent/MY184037A/en unknown
-
2014
- 2014-09-03 DO DO2014000199A patent/DOP2014000199A/es unknown
- 2014-09-03 PH PH12014501970A patent/PH12014501970A1/en unknown
- 2014-09-12 GT GT201400192A patent/GT201400192A/es unknown
- 2014-09-23 CR CR20140440A patent/CR20140440A/es unknown
- 2014-09-23 IL IL234830A patent/IL234830B/en active IP Right Grant
- 2014-09-26 MX MX2018015914A patent/MX2018015914A/es unknown
- 2014-09-26 CL CL2014002590A patent/CL2014002590A1/es unknown
- 2014-10-23 CO CO14234406A patent/CO7111293A2/es unknown
-
2016
- 2016-05-25 US US15/163,883 patent/US9879079B2/en active Active
-
2017
- 2017-11-30 CL CL2017003039A patent/CL2017003039A1/es unknown
- 2017-12-18 US US15/844,883 patent/US10465002B2/en active Active
-
2018
- 2018-05-03 AU AU2018203081A patent/AU2018203081A1/en not_active Abandoned
- 2018-06-14 CY CY20181100623T patent/CY1121466T1/el unknown
- 2018-11-22 JP JP2018218861A patent/JP6912441B2/ja active Active
-
2019
- 2019-09-24 US US16/580,603 patent/US20200115441A1/en not_active Abandoned
-
2021
- 2021-07-07 JP JP2021112483A patent/JP7411609B2/ja active Active
-
2022
- 2022-12-09 US US18/063,981 patent/US12558420B2/en active Active
-
2023
- 2023-12-22 JP JP2023216462A patent/JP2024038036A/ja active Pending
-
2025
- 2025-06-20 JP JP2025104387A patent/JP2025134874A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015513903A5 (https=) | ||
| SI2831113T1 (en) | Antibodies to bradykinin b1 receptor ligands | |
| JP2016538876A5 (https=) | ||
| FI3487882T3 (fi) | Gprc5d-vasta-aineita, bispesifisiä antigeeniä sitovia molekyylejä, jotka sitovat gprc5d:tä ja cd3:a, sekä niiden käyttötapoja | |
| RU2019111722A (ru) | Антитела против siglec-15 и способы их применения | |
| RU2013102225A (ru) | АНТИТЕЛА ПРОТИВ Axl И СПОСОБЫ ИХ ПРИМЕНЕНИЯ | |
| JP2014502955A5 (https=) | ||
| RU2014109039A (ru) | Биспецифические антигенсвязывающие молекулы | |
| RU2018102606A (ru) | Молекулы, связывающиеся с psl pseudomonas, и пути их применения | |
| RU2012137498A (ru) | Фармацевтическая композиция для лечения и/или профилактики рака | |
| RU2013141077A (ru) | Антигенсвязывающие белки | |
| JP2010526028A5 (https=) | ||
| JP2013542194A5 (https=) | ||
| RU2015144105A (ru) | Антитела к гепсидину и их применения | |
| JP2014169326A5 (https=) | ||
| RU2016137110A (ru) | Антитела к компоненту комплемента с5 | |
| RU2016137256A (ru) | АНТИТЕЛА К ФАКТОРУ КОМПЛЕМЕНТА Bb | |
| JP2012531922A5 (ja) | Ｔｏｌｌ様受容体２へのヒト化抗体またはその抗原結合部位 | |
| TWI910146B (zh) | 抗flt3抗體及組合物 | |
| RU2019134462A (ru) | Антитела, связывающиеся с steap-1 | |
| RU2013102073A (ru) | Антитела, подходящие для пассивной иммунизации против гриппа | |
| JP2021514670A5 (https=) | ||
| JP2018512124A5 (https=) | ||
| JP2016520595A5 (https=) | ||
| RU2014140116A (ru) | Антитела против pdgf-c |